On demand webinar: Unmatched viral particle analysis in vaccine and gene therapy development

The number of gene therapy applications based on viral vectors are growing and small-scale manufacturing processes are increasingly requiring scale-up to commercial processes. 

Numerous challenges must be overcome in scaling-up to full commercial production. Undesired outcomes can be avoided by careful monitoring during development of the process.

In this webinar we will show how MiniTEM can produce powerful data where traditional assays have limitations.

With the introduction of the MiniTEM™ system, transmission electron microscopy has become an accessible method for routine testing in bioprocessing. Through automated image acquisition, particle detection and classification, MiniTEM can provide both high-resolution images and reliable quantitative data in a very short turnaround time.

Key Learning Objectives

How MiniTEM automatically can:

  • Screen the viral particle morphology status throughout the process
  • Determine sample purity
  • Detect aggregates
  • Compare the portion of intact versus broken viral particles
  • Indicate virus titer

Speaker: Josefina Nilsson, head of EM services & Martin Ryner, Strategic development manager

Watch webinar here.

Sample description (optional)

Analysis objective (optional)


Study Proposal Form

Please fill out the following information with as much detail as you can, in order for us to provide you with an accurate quote as soon as possible.

* - Compulsory fields
What is the nature of the product
If relevant, where will the product be marketed
Should the study be performed in compliance with GLP
Should the study be performed in duplicate
Will a representative from your company be present during the testing
Process steps to be tested Model viruses Processing time Number of points for sampling If representative(s) will be present, please specify for which step(s)
Vironova Biosafety
Thank you for your interest.